Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Venkat Kalyan
Person

Venkat Kalyan

Tracked across 1 events · 6 articles · First seen Jun 01, 2026 · Last active Jun 02, 2026

Sentiment
60
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 60
Regulatory
UAE approves Novo Nordisk's Wegovy
The United Arab Emirates — Emirates Drug Establishment (EDE) in the United Arab Emirates has approved Semaglutide (semaglutide), an oral once-daily treatment developed by Novo Nordisk, for long-term weight management in adults with obesity or…
Impact: Venkat Kalyan, General Manager of Novo Nordisk Gulf, highlighted the collaboration with the United Arab Emirates — Emirates Drug Establishment and the well-established safety profile and convenience of the oral semaglutide formulation.
Jun 01, 2026 · 6 articles
NEWSDESK
Track Venkat Kalyan live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.